Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients willing to participate in the study 2) Patient age 40-75 years 3) ASA grade III 4) Scheduled for high dose rate (HDR) intracavitary brachytherapy 5) Diagnosed with FIGO stage IIB-IIIB carcinoma cervix.
Exclusion criteria
Exclusion criteria: 1) Patients not willing to participate in the study 2) Patients who has bleeding tendencies 3) Pregnant females 4) Patients with contraindications to spinal/epidural or general anaesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TIVA is better than sub arachnoid block in Post op pain management for 48 hours in brachytherapy patients. Timepoint: TIVA is better than sub arachnoid block in Post op pain management for 48 hours in brachytherapy patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haemodynamic stability To study the side effects and complications during the postoperative period. Post operative surgeon vs patients satisfaction.Timepoint: 24 hours | — |
Countries
India
Contacts
Datta Meghe Institution Of Higher Education And Research